- About Us
- Advertise / Support
- Editorial Board
- Contact Us
- CancerNetwork.com
- TargetedOnc.com
- OncLive.com
- OncNursingNews.com
- Terms & Conditions
- Privacy
- Do Not Sell My Information
© 2025 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
Speaking Out About Breast Implant-Associated Cancer
Kristie L. Kahl is vice president of content at MJH Life Sciences, overseeing CURE®, CancerNetwork®, the journal ONCOLOGY, Targeted Oncology, and Urology Times®. She has been with the company since November 2017.
In this episode of CURE® Talks Cancer, we spoke with an advocate who is raising awareness around the recent controversy surrounding a certain type of breast implant that is causing a rare type of lymphoma.
Imagine overcoming a breast cancer diagnosis and its treatment, yet in choosing reconstructive surgery with textured implants, finding out you may be at risk for a rare type of lymphoma.
Renee Ridgeley found herself in that exact situation.
Following the recent controversy with a Food and Drug Administration panel not banning these implants that are to blame for causing breast implant-associated anaplastic large-cell lymphoma, many women are speaking out about the issue.
In this week’s CURE® Talks Cancer podcast, we spoke with the patient advocate about her own experience and how women can learn more about their reconstruction options.
Related Content:
